Changyou Zhan (占昌友)

Changyou Zhan (占昌友)

Harvard University

H-index: 46

North America-United States

About Changyou Zhan (占昌友)

Changyou Zhan (占昌友), With an exceptional h-index of 46 and a recent h-index of 35 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Targeted Drug Delivery, Peptide Drug Discovery, Brain tumor.

His recent articles reflect a diverse array of research interests and contributions to the field:

Anti-PEG antibodies: Current situation and countermeasures

Reexamining in vivo fate of paclitaxel-loaded polymeric micelles

Reexamining the effects of drug loading on the in vivo performance of PEGylated liposomal doxorubicin

Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein

mIgM-mediated splenic marginal zone B cells targeting of folic acid for immunological evasion

Effects of PEG antibodies on in vivo performance of LNP-mRNA vaccines

Design, Synthesis, Formulation, and Bioevaluation of Trisubstituted Triazines as Highly Selective mTOR Inhibitors for the Treatment of Human Breast Cancer

Phospholipid Type Regulates Protein Corona Composition and In Vivo Performance of Lipid Nanodiscs

Changyou Zhan (占昌友) Information

University

Position

Boston Children's Hospital, Harvard Medical School; Koch Institute, MIT

Citations(all)

6507

Citations(since 2020)

3907

Cited By

4102

hIndex(all)

46

hIndex(since 2020)

35

i10Index(all)

98

i10Index(since 2020)

89

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Changyou Zhan (占昌友) Skills & Research Interests

Targeted Drug Delivery

Peptide Drug Discovery

Brain tumor

Top articles of Changyou Zhan (占昌友)

Title

Journal

Author(s)

Publication Date

Anti-PEG antibodies: Current situation and countermeasures

Jiaru Fu

Ercan Wu

Guanghui Li

Bin Wang

Changyou Zhan

2024/4/1

Reexamining in vivo fate of paclitaxel-loaded polymeric micelles

Nano Today

Shiqi Lin

Yifei Yu

Ercan Wu

Tianhao Ding

Yuxiu Chu

...

2024/6/1

Reexamining the effects of drug loading on the in vivo performance of PEGylated liposomal doxorubicin

Acta Pharmacologica Sinica

Yi-fei Yu

Er-can Wu

Shi-qi Lin

Yu-xiu Chu

Yang Yang

...

2024/3

Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein

Tianlei Ying

Yulu Wang

Yifang Sun

Zhaoling Shen

Cong Wang

...

2024/4/29

mIgM-mediated splenic marginal zone B cells targeting of folic acid for immunological evasion

Acta Pharmaceutica Sinica B

Huan Wang

Zhuxuan Jiang

Zhiwei Guo

Gan Luo

Tianhao Ding

...

2024/2/1

Effects of PEG antibodies on in vivo performance of LNP-mRNA vaccines

International Journal of Pharmaceutics

Min Yang

Zengyu Zhang

Pengpeng Jin

Kuan Jiang

Yifei Xu

...

2024/1/25

Design, Synthesis, Formulation, and Bioevaluation of Trisubstituted Triazines as Highly Selective mTOR Inhibitors for the Treatment of Human Breast Cancer

Journal of Medicinal Chemistry

Qiwen Sun

Yuxiu Chu

Nana Zhang

Rui Chen

Lili Wang

...

2024/4/25

Phospholipid Type Regulates Protein Corona Composition and In Vivo Performance of Lipid Nanodiscs

Molecular Pharmaceutics

Feng Pan

Mengyuan Liu

Guanghui Li

Boqian Chen

Yuxiu Chu

...

2024/4/12

A natural IgM hitchhiking strategy for delivery of cancer nanovaccines to splenic marginal zone B cells

Journal of Controlled Release

Huan Wang

Xiying Wu

Yuhan Sun

Anze Liu

Yingying He

...

2024/4/1

Lipid‐Based Nanocarriers Enabled Oral Delivery of Oleanolic Acid Derivative DKS26 for Diabetes Management

Advanced Healthcare Materials

Yujuan Ban

Yuxiu Chu

Feng Pan

Zhiwei Guo

Yang Yang

...

2023/6

Protein corona on brain targeted nanocarriers: challenges and prospects

Kuan Jiang

Yifei Yu

Wei Qiu

Kaisong Tian

Zhiwei Guo

...

2023/10/11

Interplay between Liposomes and IgM: Principles, Challenges, and Opportunities

Huan Wang

Shiqi Lin

Xiying Wu

Kuan Jiang

Huiping Lu

...

2023/7

Peptide-decorated nanocarriers penetrating the blood-brain barrier for imaging and therapy of brain diseases

Xihui Gao

Jinliang Xu

Tingting Yao

Xiaoxiao Liu

Hanchang Zhang

...

2022/8/1

Engineered platelets-based drug delivery platform for targeted thrombolysis

Acta Pharmaceutica Sinica B

Songli Wang

Ruifeng Wang

Nana Meng

Linwei Lu

Jun Wang

...

2022/4/1

Protein corona mediated liposomal drug delivery for bacterial infection management

Asian Journal of Pharmaceutical Sciences

Qianwen Shao

Tianhao Ding

Feng Pan

Guanghui Li

Shun Shen

...

2022/11/1

Protein corona: challenges and opportunities for targeted delivery of nanomedicines

Zhuxuan Jiang

Yuxiu Chu

Changyou Zhan

2022/7/3

NIR light‐triggered quantitative pulsed drug release

Advanced Healthcare Materials

Yang Yang

Kaiqi Long

Yiqun Wang

Lei Li

Jiayue Shi

...

2022/4

Morphology-driven protein corona manipulation for preferential delivery of lipid nanodiscs

Nano Today

Tao Chen

Feng Pan

Gan Luo

Kuan Jiang

Huan Wang

...

2022/10/1

Compositions and methods for on-demand high-efficiency triggerable anesthesia

2022/5/31

H2S‐Responsive Small‐Molecule Nanocarriers for Drug Delivery to Colorectal Tumors (Adv. Therap. 9/2022)

Advanced Therapeutics

Kaiqi Long

Yang Yang

Zhanfeng Du

Weirong Kang

Wen Lv

...

2022/9

See List of Professors in Changyou Zhan (占昌友) University(Harvard University)

Co-Authors

H-index: 319
Robert Langer

Robert Langer

Massachusetts Institute of Technology

H-index: 67
Wuyuan Lu

Wuyuan Lu

University of Maryland, Baltimore

H-index: 34
Cong Li

Cong Li

Fudan University

H-index: 31
QIAN LIU

QIAN LIU

Fudan University

H-index: 27
Jie Shen

Jie Shen

University of Rhode Island

academic-engine